- Global Pharma News & Resources

Global Injectable Drug Delivery Market Analysis & Trends 2017-2027 -

The "Global Injectable Drug Delivery Market Analysis & Trends - Industry Forecast to 2027" report has been added to's offering.

The Global Injectable Drug Delivery Market is poised to grow strong during the forecast period 2017 to 2027

Some of the prominent trends that the market is witnessing include rising demand for injectable drug delivery in biologics market, rising demand for biosimilars and increasing demand for adoption of self-injection devices.

This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027.

The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc.

Report Highlights:

  • The report provides a detailed analysis on current and future market trends to identify the investment opportunities
  • Market forecasts till 2027, using estimated market values as the base numbers
  • Key market trends across the business segments, Regions and Countries
  • Key developments and strategies observed in the market
  • Market Dynamics such as Drivers, Restraints, Opportunities and other trends
  • In-depth company profiles of key players and upcoming prominent players
  • Growth prospects among the emerging nations through 2027
  • Market opportunities and recommendations for new investments

Key Topics Covered:

1 Market Outline

2 Executive Summary

3 Market Overview

3.1 Current Trends

3.1.1 Rising Demand for Injectable Drug Delivery in Biologics Market

3.1.2 Rising Demand for Biosimilars

3.1.3 Increasing Demand for Adoption of Self-Injection Devices

3.1.4 Growth Opportunities/Investment Opportunities

3.2 Drivers

3.3 Constraints

3.4 Industry Attractiveness

4 Injectable Drug Delivery Market, By Formulation Packaging

4.1 Vials

4.2 Bottles

4.3 Cartridges

4.4 Ampules

5 Injectable Drug Delivery Market, By Usage Pattern

5.1 Immunization

5.2 Curative Care

5.3 Other Usage Patterns

6 Injectable Drug Delivery Market, By Type

6.1 Formulation

6.1.1 Novel Drug Delivery Formulations Long Acting Injection Formulation Microparticles Microcapsules Microspheres Colloidal Dispersions Nanoparticles Nanosuspensions Nanoemulsions Solid-Lipid Nanoparticles Polymeric/Mixed Micelles Liposomes Niosomes

6.1.2 Conventional Drug Delivery Formulations Suspensions Solutions Reconstituted/Lyophilized Formulations Emulsions

6.2 Device

6.2.1 Self Injection Devices Needle Free Injectors (NFI) Technology Product Usability Wearable Injectors Pen Injectors Design Product Usability Auto Injectors Technology Design Product Usability Other Devices

6.2.2 Conventional Injection Devices Product Material Usability

7 Injectable Drug Delivery Market, By Site Of Administration

7.1 Organs

7.2 Skin

7.3 Central Nervous System

7.4 Circulatory/Musculoskeletal System

8 Injectable Drug Delivery Market, By Distribution Channel

8.1 Pharmacy Stores

8.2 Hospital Pharmacy

8.3 Online Pharmacy

8.4 Direct Tender

9 Injectable Drug Delivery Market, By Application

9.1 Orphan Disease

9.2 Oncology

9.3 Autoimmune Diseases

9.3.1 Rheumatoid Arthritis

9.3.2 Multiple Sclerosis

9.3.3 Crohn's Diseases

9.3.4 Psoriasis

9.3.5 Other Autoimmune Diseases

9.4 Hormonal Disorder

9.4.1 Anemia

9.4.2 Reproductive Health Disease

9.4.3 Antithrombotic/Thrombolytic Therapy

9.4.4 Osteoporosis

9.4.5 Growth Hormone Disorders (GHD)

9.5 Other Applications

9.5.1 Pain Management

9.5.2 Allergy Treatment

9.5.3 Aesthetic Treatments

9.5.4 Hepatitis C

9.5.5 Hemophilia

10 Injectable Drug Delivery Market, By End User

10.1 Home Healthcare Settings

10.2 Hospitals And Clinics

10.3 Pharmaceutical & Biotechnological Companies

10.4 Research Laboratories

10.5 Other End Users

11 Injectable Drug Delivery Market, By Geography

12 Key Player Activities

12.1 Acquisitions & Mergers

12.2 Agreements, Partnerships, Collaborations and Joint Ventures

12.3 Product Launch & Expansions

12.4 Other Activities

13 Leading Companies

  • Gerresheimer AG
  • Baxter International, Inc.
  • Pfizer, Inc.
  • Alkermes Plc.
  • Becton Dickinson and Company
  • Eli Lilly and Company
  • Schott AG
  • Sandoz
  • Teva Pharmaceuticals Industries Ltd.
  • Bespak
  • Ypsomed
  • Terumo Corporation
  • Elcam Medical
  • Unilife Corporation
  • Endocyte

For more information about this report visit

View source version on

Editor Details

Last Updated: 26-Nov-2018